- Clinical Trials
- January 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
Prostaglandin Antagonists are a class of drugs used to treat immune disorders. They work by blocking the action of prostaglandins, which are hormones that play a role in inflammation and other immune responses. Prostaglandin Antagonists are used to treat a variety of conditions, including asthma, allergies, and autoimmune diseases. They can also be used to reduce the risk of organ rejection in transplant patients.
The Prostaglandin Antagonist market is a growing one, with a variety of drugs available to treat a range of immune disorders. These drugs are often used in combination with other treatments, such as corticosteroids, to provide the best possible outcome for patients.
Some of the companies in the Prostaglandin Antagonist market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies produce a range of drugs, including anti-inflammatory drugs, corticosteroids, and immunosuppressants. Show Less Read more